Spanish researchers have discovered that dermcidin, a natural antimicrobial peptide found in human sweat, saliva, and tears, may explain why an estimated 5–35% of people exposed to influenza never develop symptoms. Scientists at Spain's Fisabio Foundation analyzed samples from 19 healthcare workers who remained healthy despite constant flu exposure, finding dermcidin levels approximately six times higher in their throats compared to susceptible peers.
The protein works by binding to hemagglutinin, a critical viral surface protein, triggering structural changes that prevent the virus from fusing with cell membranes and initiating infection. "Dermcidin acts on regions of the virus that hardly change between subtypes," said study director Dr. María D. Ferrer, suggesting the molecule could offer broad protection across multiple flu variants. Mouse experiments confirmed dermcidin's protective effects against influenza A.
Published in the Proceedings of the National Academy of Sciences, the findings could pave the way for new antiviral treatments based on a molecule the human body already produces. With influenza infecting up to 1 billion people globally each year, understanding natural resistance mechanisms offers a promising path toward better prevention strategies.